Sex-dependent effects of developmental arsenic exposure on methylation capacity and methylation regulation of the glucocorticoid receptor system in the embryonic mouse brain  by Allan, Andrea M. et al.
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Previously  we  have  shown  that prenatal  moderate  arsenic  exposure  (50  ppb)  disrupts  glucocorticoid
receptor  (GR)  programming  and  that  these  changes  continue  into  adolescence  in  males.  However,  it
was  not  clear  what  the  molecular  mechanisms  were  promoting  these  GR  programming  changes  or  if
these changes  occurred  in  arsenic-exposed  females.  In the  present  studies,  we  assessed  the  effects  of
arsenic  on  protein  and  mRNA  of  the  glucocorticoid  receptor  (GR)  and  11-hydroxysteroid  dehydroge-
nase  (Hsd)  isozymes  and  compared  the  levels  of methylation  within  the  promoters  of  the  Nr3c1  and
Hsd11b1  genes  in  female  fetal  brain  at embryonic  days  (E)  14 and  18. Prenatal  arsenate  exposure  pro-
duced  sex  speciﬁc  effects  on the glucocorticoid  system.  Compared  to  males,  females  were  resistant  to
arsenic  induced  changes  in GR, 11-Hsd-1  and  11-Hsd-2  protein  levels  despite  observed  elevations
in  Nr3c1  and Hsd11b2  mRNA.  This  sex-speciﬁc  effect  was  not  due  to differences  in  the  methylation  of
the  GR  promoter  as  methylation  of  the  Nr3c1  gene  was  either  unchanged  (region  containing  the  egr-1
binding  site)  or  similarly  reduced  (region  containing  the  SP-1  transcription  factor  binding  site)  in both
males  and  females  exposed  to arsenic.  Arsenic  did  produce  sex and  age-speciﬁc  changes  in  the  methyla-
tion  of Hsd11b1  gene,  producing  increased  methylation  in  females  at E14  and  decreased  methylation  at
E18.These  changes  were  not  attributed  to  changes  in DNMT  levels.  Since  arsenate  metabolism  could  inter-
fere  with  the  generation  of  methyl  donor  groups,  we assessed  glutathione  (GSH),  S-adenosylmethionine
(SAM)  and  As  3 methyltransferase  (As3MT).  Exposed  males  and  females  had  similar  levels of As3MT
and  SAM;  however,  females  had  higher  levels  of  GSH/GSSH.  It is possible  that  this  greater  anti-oxidative
capacity  within  the  females  provides  protection  against  low  to  moderate  arsenate.  Our  data  suggest  that
the GR  signaling  system  in  female  offspring  was  not  as  affected  by  prenatal  arsenic  and  predicts  that
female  arsenic-exposed  mice  should  have  normal  GR  feedback  regulation.
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC. Introduction
It is estimated that over 100 million people are exposed to
rsenic via drinking water. The World Health Organization (WHO)
ecommends that 0.010 mg/l (10 ppb) arsenic in water is safe for
ngestion. While the WHO  standard is in the parts-per-billion range,
everal millions of people worldwide either consume unregulated
ell-water or live in regions where the standard amount of arsenic
∗ Corresponding author at: Department of Neurosciences, MSC 08 4740, 1 Uni-
ersity of New Mexico, Albuquerque, NM 87131, USA. Tel.: +1 505 272 8811.
E-mail address: aallan@salud.unm.edu (A.M. Allan).
ttp://dx.doi.org/10.1016/j.toxrep.2015.10.003
214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
is in the parts-per-million range. Arsenic is a common, pervasive
environmental contaminant that affects almost every major organ
system in the body including the brain. Inorganic arsenic, found
in drinking water, exists in two oxidation states as As3+ (arsen-
ite) and As5+ (arsenate), both of which readily accumulate in the
body. While arsenite is considered to be more toxic than arsenate
because of its thiol reactivity, both inorganic forms are considerably
more toxic than their organic counterparts [19] and arsenate is con-
verted to arsenite in vivo through the activity of a purine nucleoside
phosphorylase, arsenate reductase. Arsenic biotransformation after
ingestion involves several redox reactions and associated methyla-
tion steps to form arsenical species that are excreted from the body;
these include the trivalent and pentavalent forms of inorganic
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Fig. 1. The effect of prenatal arsenic (50 ppb) in female post nuclear (PNL) and nuclear (Nuc) fractions from E14 and E18 brain. Protein expression of Glucocorticoid receptor
(GR),  11B-HSD1 and 2 in the arsenic exposed group (ﬁlled bars) compared to control (open bars), did not differ. Data are mean ± SEM, n = 7–9. The intensity of the speciﬁc
antibody was corrected to within blot Coomassie stain as described in (Caldwell et al., 2015).
Fig. 2. Prenatal arsenic (50 ppb) signiﬁcantly increase the level of mRNA expression of Nr3c1 (GR) and Hsd11b2 (11b-hydroxysteroid dehydrogenase 2) in E14 female brain,
b ydrox
e d. Dat
t
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iut  there was  no effect of arsenic at E18.No effect on the levels of Hsd11b1 (11b-h
xpression of the target genes were acquired by the Ct (Comparative CT) metho
he  ﬁlled columns and controls presented in the unﬁlled columns.
rsenic and the mono- and dimethylated metabolites of each inor-
anic form. Several studies have demonstrated that the speciation
f arsenic, not only the total exposure, impacts type and sever-
ty of molecular dysfunction [9,47]. Metabolism of arsenic afterysteroid dehydrogenase 1) was observed at either developmental time-point. Fold
a presented are mean ± SEM n = 7–11, *p = .04, **p = 0.005. Arsenic are presented in
exposure actually produces more toxic species (conversion of arse-
nate to arsenite) using glutathione (GSH) and other thiol groups as
reducing agents. Arsenite is then distributed throughout tissues
into cytosol where it undergoes methylation, which requires
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Fig. 3. Prenatal arsenic (50 ppb) signiﬁcantly decreased the level of methylation within the SP-1 binding site region of Nr3c1 (see Supplemental Fig. 1) in E14 female and
male  brain. No effect of prenatal arsenic was seen for either sex on the levels of Nr3c1 methylation at either developmental time-point. The levels of methylation within
region 1 of Nr3c1 (see Supplemental Fig. 1) was assessed by MeDIP qPCR (see methods). Region 1 primers were developed to encompass the SP-1 transcription factor binding
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site.Data are expressed as mean fold methylation +/− SEM, n = 5–7 different litters. 
nd  E18 (B and D) brains. Arsenic are presented in the ﬁlled columns and controls p
 = 0.05.
-adenosyl methionine (SAM) as the methyl donor. This has
ed several investigators to suggest that arsenic may  deplete
he levels of SAM in the body, thereby reducing the levels of
ethyl donors available for DNA methylation, leading to aber-
ant DNA methylation and other aberrant epigenetic processes
ncluding histone posttranslational modiﬁcations that require
ethyl groups [32,33,8,1,24,26,30,43]. However, the mechanisms
y which arsenic impedes epigenetic processes are still under
nvestigation.
There are several components of epigenetic gene regulation
ncluding DNA methylation, histone posttranslational modiﬁca-
ions (PTM), and noncoding RNAs. DNA methylation, located at CpG
inucleotides, is the most widely studied component of epigenet-
cs. Three highly conserved enzymes, the DNA methyltransferases
DNMT1, DNMT3A, DNMT3B), impart single methyl groups (CH3)
rom the universal methyl donor S-adenosyl methionine (SAM).
hese methylated CpG sites can occur in heterochromatin, or
egions of the DNA not actively transcribed. CpG regions are present
n 5′ regulatory regions of genes including transcriptional start sites
nd are typically unmethylated, with only 10% containing DNA
ethylation [13]. CpG dinucleotides within promoters without CpGslands are usually methylated based on the tissue speciﬁcity and
re indicative of the transcriptional status of the gene. In essence,
ethylation of a CpG is indicative of repression of gene expres-
ion, while demethylation of a CpG can be indicative of activeom male (A and B) and female (C and D) are presented separately for E14 (A and C)
ed in the unﬁlled columns. E14 male t(10) = 2.6, p = 0.03, and E14 female t(10) = 2.2,
transcription [10]. Genes that contain CpG islands, short (0.5–4 kb)
stretches of CG rich DNA, include most constitutively expressed
genes and genes important for developmental regulation [38]. CpG
islands are often unmethylated, where methylation then is able to
permit dynamic and temporal regulation of gene expression. DNA
methylation is critical to development of an organism, and in the
context of developmental toxins, is the most widely studied epi-
genetic mechanism for toxicity [40]. If arsenic exposure reduces
methylation capacity or alters the machinery necessary for methy-
lation, then this could result in aberrant DNA methylation and gene
expression patterns.
Recent work in our lab has shown that prenatal arsenic expo-
sure alters glucorticoid programming [22,20,21,11,42,4,43]. This
altered programming occurs in utero and can be detected as early
as embryonic day 14 [4]. The changes to the glucocorticoid system
are perpetuated into adulthood animal [20,21,11]. However, our
previous work focused only on males and the impact of arsenic on
female offspring was  not assessed.The goal of the studies presented
here are to compare the impact of arsenic on male and female off-
spring.
In an effort to identify the molecular mechanism for arsenic-
induced changes to the glucocorticoid receptor system, we  have
evaluated the levels of DNA methylation within speciﬁc regions of
the promoter regions of the glucocorticoid receptor gene (Nr3c1)
and 11HSD1 gene (Hsd11B1), a critical hydroxysteroid dehydro-
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Table  1
Antibody source concentration and product information.
Age/fraction/tissue Total protein Antibody concentration Target protein Product code Company
E14
Nuclear
male
whole
brain
12 g [1:1000] C-Jun cs#9185 Cell signaling
12  g [1:1000] SP 1 sc-14027 Santa Cruz biotechnology
18  g [1:1000] Egr-1 cs#4153 Cell signaling
12  g [1:500] Dnmt1 sc-20701 Santa Cruz biotechnology
15  g [1:1000] Dnmt3b sc-20704 Santa Cruz biotechnology
15  g [1:1000] Dnmt3a M0229S New England biolabs
15  g [1:500] MeCP 2 sc-5755 Santa Cruz biotechnology
E14
Nuclear
female
whole
brain
12  g [1:1000] C-Jun cs#9185 Cell signaling
12  g [1:1000] SP1 sc-14027 Santa Cruz biotechnology
18  g [1:1000] Egr-1 cs#4153 Cell signaling
12  g [1:500] Dnmt1 sc-20701 Santa Cruz biotechnology
15  g [1:1000] Dnmt3b sc-20704 New England biolabs
15  g [1:1000] Dnmt3a M0229S Santa Cruz biotechnology
15  g [1:500] MeCP 2 sc-5755 Santa Cruz Biotechnology
13.5  g [1:500] As3MT sc-376537 Santa Cruz Biotechnology
E18
Nuclear
male
whole
brain
13.5  g [1:1000] c-Jun cs#9185 Cell signaling
13  g [1:1000] SP1 sc-14027 Santa Cruz biotechnology
18  g [1:1000] Egr-1 cs#4153 Cell signaling
12  g [1:500] Dnmt1 sc-20701 Santa Cruz biotechnology
15  g [1:1000] Dnmt3b sc-20704 Santa Cruz biotechnology
15  g [1:1000] Dnmt3a M0229S New England biolabs
15  g [1:500] MeCP 2 sc-5755 Santa Cruz biotechnology
13.5  g [1:500] As3MT sc-376537 Santa Cruz biotechnology
13  g [1:1000] SP1 sc-14027 Santa Cruz biotechnology
E18
Nuclear
female
whole
brain
14  g [1:1000] c-Jun cs#9185 Cell signaling
14  g [1:1000] SP1 sc-14027 Santa Cruz biotechnology
18  g [1:1000] Egr-1 cs#4153 Cell signaling
12  g [1:500] Dnmt1 sc-20701 Santa Cruz biotechnology
15  g [1:1000] Dnmt3b sc-20704 Santa Cruz biotechnology
15  g [1:1000] Dnmt3a M0229S New England biolabs
15  g [1:500] MeCP 2 sc-5755 Santa Cruz biotechnology
13.5  g [1:500] As3MT sc-376537 Santa Cruz Biotechnology
20  g [1:500] GR sc-1004 Santa Cruz biotechnology
20  g [1:500] HSD11b2 sc-20176 Santa Cruz biotechnology
20  g [1:500] HSD11b1 sc-19259 Santa Cruz biotechnology
Table 2
Levels of SAM and SAH determined in brain (top table) and liver (bottom table) in arsenic and control E14 and E18 male and female tissues. Data are presented as average
(+/−  SEM) in nmol/g tissue wet weight from n = 5–6.
Brain E14 male E14 female E18 male E18 female
Control Arsenic Control Arsenic Control Arsenic Control Arsenic
SAM 2.3 (±0.5) 2.3 (±0.6) 2.6 (±0.5) 2.5 (±0.4) 4.0 (±0.4) 3.5 (±0.7) 4.1 (±0.5) 4.7 (±0.2)
SAH  0.12 (±0.02) 0.07 (±0.02) 0.10 (±0.03) 0.13 (±0.02) 0.08 (±0.001) 0.08 (±0.002) 0.06 (±0.001) 0.08 (±0.001)
Liver E14 male E14 female E18 male E18 female
Control Arsenic Control Arsenic Control Arsenic Control Arsenic
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wSAM 2.1 (±0.2) 2.4 (±0.2) 2.5 (±0.2) 2.1
SAH  0.15 (±0.03) 0.23 (±0.03) 0.29 (±0.03) 0.2
enase linked to glucocorticoid sensitivity. 11HSD1 is an oxore-
uctase which converts inactive cortisone to active corticosterone
nd increases in expression during fetal development. In addition,
e assessed levels of DNMTs, the DNA methyl binding protein
MeCP2), and transcription factors which regulate the expression
f GR. Finally, we assessed the metabolic enzymes involved in
rsenic metabolism in embryos from male and female exposed
ice.
. Materials and methods.1. Chemical hazards
Arsenic is classiﬁed as a human co-carcinogen; all arsenicals
ere handled with caution in accordance with MSDS standards.) 6.3 (±0.5) 5.1 (±0.5) 6.5 (±0.4) 6.6 (±0.4)
.03) 4.0 (±0.4) 6.8 (±0.7) 4.5 (±0.3) 5.1 (±0.05)
2.2. Prenatal arsenic exposure (PAE) paradigm
The Institutional Animal Care and Use Committee at the Uni-
versity of New Mexico (UNM) approved the animal protocols,
including the arsenic exposure paradigm, used in this study.
C57BL/6 mice obtained from Jackson Labs were maintained on a
12 h reverse light/dark cycle (lights off at 08:00 and lights on at
20:00 h) with ad libitum access to food and water in the Animal
Resource Facility at UNM. Arsenic exposure was performed as pre-
viously described [44]. Brieﬂy, singly-housed female mice aged 55
days were acclimated to drinking 50 parts-per-billion (ppb) arsenic
water (sodium arsenate, Sigma–Aldrich) for 10 days prior to mat-
ing.The 50 ppb level was chosen due to the fact that water standard
prior to 2006 in the United States was 50 ppb. Moreover, the detoxi-
ﬁcation capacity of the mouse liver is signiﬁcantly greater than that
of humans [17,2] making the 50 ppb concentration more relevant to
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Fig. 4. There were no differences in the levels of methylation within the Egr-1 binding site (Region 6) in Nr3c1 between male and female at either developmental time-point.
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he  Egr-1 transcription factor binding site. Data are expressed as mean fold methyla
resented separately for E14 (A and C) and E18 (B and D) brains. Arsenic exposed an
uch lower human exposures. Arsenic water was prepared weekly
sing standard tap water. Control mice were administered tap
ater which contains approximately 2–5 ppb arsenic. Tap water
as chosen as the control as there are key minerals which would
e missing from Milli-Q water. It is likely that the local tap water
ontains pesticides. These were not measured or controlled for in
his study. Female mice were paired with breeding males for a
ingle day. Pregnant females (dams) continued to drink arsenic-
aced water throughout pregnancy until fetuses were removed at
14 or E18. Dams were decapitated and embryos removed. Fetal
elencephalon and liver were dissected and frozen in liquid nitro-
en. Male and female embryos were identiﬁed using qPCR of Sry
evels in DNA extracted from the embryo body as described pre-
iously [4]. For each experiment, at least 7 different litters from
ifferent dams were used; e.g., n = 7 represents the number of
ifferent litters used with one animal per litter to avoid litter
ffects.
.3. DNA methylation analysis of Nr3c1 and Hsd11b1Evaluation of methylation status of was completed with a
ethylated DNA Immunoprecipitation (MeDIP)-qPCR assay. Whole
rozen (−80 ◦C) embryonic mouse brains were homogenized and
DNA was extracted using the Qiagen DNeasy Blood & Tissueed by MeDIP qPCR see methods). Region 1 primers were developed to encompass
/− SEM, n = 5–7 different litters. Data from male (A and B) and female (C and D) are
 are presented in the ﬁlled columns and controls presented in the unﬁlled columns.
Kit (cat #: 69504; Valencia, CA) according to the manufacturer’s
methods. gDNA samples were treated with Life Technologies Pure-
Link RNase A (cat #: 12091-021; Grand Island, NY) to remove
any contaminating RNA. gDNA was quantiﬁed with the Qubit®
dsDNA HS Assay Kit (cat #: Q32851; Life Technologies) on a
Qubit® 2.0 Fluorometer. MeDIP was  conducted using the Epi-
gentek Methylamp Methylated DNA Capture (MeDIP) Kit (cat #:
P-1015-24; Farmingdale, NY). 2 g of gDNA from each sample
was fragmented with a Kontes Micro Ultrasonic Cell Disrupter
(model: KT50) by 3 × 12 s pulses at 20% separated by 40 s incu-
bations on ice. gDNA fragment sizes ranged from 200 to 1000 bp
with an average of about 600 bp and were veriﬁed on a 3%
agarose gel. The 2 g of fragmented gDNA were then divided
into two equal reactions and melted at 95 ◦C for 10 min  then
placed immediately on ice. 5 l of each melt reaction (10 l
total per sample) was set aside as Input DNA. The remain-
ing pair of IP samples was  then processed with the MeDIP kit
per the user manual only to be merged into one ﬁnal elution
volume of 20 l. Input and IP ssDNA was quantiﬁed with the
Qubit® ssDNA Assay Kit (cat #: Q10212). ssDNA Input and IP
samples were run on a LightCycler 96 qPCR instrument (Roche
Diagnostics, Indianapolis, IN) with Roche FastStart Essential DNA
Green Master (cat #: 6402712001). qPCR primers (Supplemental
Figs. 1 and 2) were designed against gene promoter CpG island
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Fig. 5. Prenatal arsenic (50 ppb) signiﬁcantly decreased the level of methylation of Hsd11b1 (see Supplemental Fig. 2) in E14 female brain, while increasing methylation in
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egions with putative or functional transcription factor binding
ites using the NCBI Primer-BLAST online software [52]. Primer
fﬁciencies were found to be between 90 and 110%. qPCR dis-
ociation curves and gel electrophoresis were used to determine
rimer speciﬁcity. qPCR was conducted under standard proﬁle
onditions. Data were analyzed using the relative quantiﬁcation
ethod with the Input DNA as an endogenous control. MeDIP reac-
ion efﬁciencies were determined and Cq values were adjusted
o account for efﬁciency variances. Statistical signiﬁcance was
etermined by Student’s t-test using GraphPad Prism 6 soft-
are.
.4. Nr3c1, Hsd11b1, and Hsd11b2 mRNA assessment
mRNA levels for Nr3c1, Hsd11b1, and Hsd11b2 were deter-
ined using previously published methods [4].
.5. Tissue preparation for protein quantiﬁcation
Frozen (−80 ◦C) mouse brain tissue, post nuclear lysate
PNL) and nuclear (NUC) fractions were prepared from
mbryonic day 14 (E14) and E18 brain. The PNL contains
oth the membrane and cytosolic fractions. Tissue fractions
ere homogenized and prepared following established proto-
ols [4].in male brain following arsenic exposure at either developmental time-point. Data
 (A and B) and female (C and D) are presented separately for E14 (A and C) and E18
e unﬁlled columns. t(10) = 2.47, p = 0.033 for E14 and t(10) = 3.07, p = 0.012.
2.6. Western assessment
Immunoblotting for DNA methylation related proteins (MeCp2,
DNMT1, DNMT3a, DNMT3b), transcription factors (Egr-1, SP-1,
and cJun/Ap-1), and arsenic 3 methyltransferase (As3MT) was
conducted essentially as previously described using our estab-
lished protocols [11,44]. Brain tissue lysates from one animal
were prepared and the nuclear fraction (NUC) and post nuclear
lysate (PNL, containing cytosolic and membrane proteins) iso-
lated for protein expression analysis. Total protein concentration
was determined by Bradford assay. Antibody and protein opti-
mization was  performed for each target protein in each type and
fraction of tissue; Coomassie staining was demonstrated to be
linear for all protein concentrations used. Membranes were incu-
bated overnight at 4 ◦C in primary antibodies diluted in PBS-T (see
Table 1). Membranes were washed, then incubated for 45 min in
their respective secondary antibodies solutions ([1:15,000], 0.01%
SDS, 0.1% Tween, in PBS pH 7.4). Secondary antibodies were
from Li-COR: rabbit IRDye 680RD 926-68073 and mouse IRDye
800CW 926-32212. Quantiﬁcation of protein expression was per-
formed using Image Studio version 4.1. Blots were normalized
by Coomassie staining using IRDye® Blue Protein Stain (LI-COR;
#3343C056) or with traditional Coomassie staining solution (0.1%
(w/v) Coomassie Brilliant Blue R-250, 50% methanol, 7% Glacial
Acetic Acid, in ultra-pure H2O) [27]. Values are presented as protein
expression normalized to Coomassie staining and renormalized to
controls.
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Fig. 6. The effect of prenatal arsenic (50 ppb) in male (top row) and female (bottom row) nuclear (Nuc) fractions from E14 (left column) and E18 (right column) brain on
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.7. Evaluation of glutathione levels
Glutathione levels were determined usinga colorimetric assay
Detect X, Arbor Assays #K006-H1, Ann Arbor, MI) as described
y the manufacturer. Levels of glutathione disulﬁde (GSSG or
SSH) and glutathione (GSH) at both endpoint (4 min) and kinetic
minute-by-minute analysis) were determined using a TECAN plate
eader (Inﬁnite M200, analyzed using Magellan software).
.8. Speciation of arsenic
Speciation analysis of arsenite was performed as previously
eported [4] using HPLC-ICP-MS male and female E18 brain tis-
ue. Quantiﬁcation was conducted using calibration standards for
rsenite (AsIII), Arsenate (AsV), Monomethyl Arsenic (MMA), and
imethyl Arsenic (DMA) which were prepared similar to the tissue
amples using the buffered mobile phase (2 mM octanesulfonic acid
nd 2 mM malonic acid, pH 7). The detection limit was 0.010 g/L
or iAsIII DMA, MMA  and iAsV. The system was calibrated using a
lank and four point calibration standards. Samples were analyzed
n automated mode. Chromatogram retention times were adjusted,
eaks were identiﬁed, and the calibration curves linearity was ver-
ﬁed for each species. The analytical data were reprocessed and
alidated.en bars), did not differ. Data are mean ± SEM, n = 7–9. The intensity of the speciﬁc
15).
2.9. SAM/SAH level analysis
Levels of SAM and SAH were determined by HPLC using the
method described by She et al. [37]. SAM (iodide salt), SAH, HPLC
grade methanol, and 1-heptanesulfonic acid were obtained by
Sigma–Aldrich (St. Louis, MO). Ammonium dihydrogen phosphate
(99.9% pure) was  obtained from Acros Organics (New Jersey, USA).
SAM and SAH standards were dissolved in sample buffer (4% per-
chlorate, 1% sodium metabisulﬁte, and 1% EDTA) and then diluted
to generate a standard range of 25, 50,100, 200, 400 pmol. Tissues
were weighted, diluted in 4× volume of the sample buffer, and
sonicated. They were centrifuged at 750 × g for 5 min  and ﬁltered
using cellulose acetate spin columns (0.45 m)  and then placed
in autosampler vials for HPLC detection. The HPLC system was  a
PerkinElmer Flexar system equipped with an injector, column oven,
and a UV detector set at 254 nm and a Flexar 225/275 autosam-
pler. A TSKgel ODS-80Tm column (25 cm × 4.6 mm,  5 m,  Tosoh
Co., Tokyo, Japan) was used. The column was  maintained at 35 ◦C
while samples in the autosampler were held at 20 ◦C. The mobile
phase was  40 mM NH4H2PO4, 8 mM 1-heptanesulfonic acid sodium
salt, and 18% (v/v) methanol, pH 3.0 by HCl and ﬁltered through a
0.45 m ﬁlter. The mobile phase was isocratically applied with a
ﬂow rate of 1 ml/min.Under these conditions, the SAH peak was
seen at approximately 28 min  and the SAM peak at 32 min. Data
were analyzed using the Chromera software.
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Fig. 7. The effect of prenatal arsenic (50 ppb) in male (top row) and female (bottom row) nuclear (Nuc) fractions from E14 (left column) and E18 (right column) brain on
DNMT3a protein expression. Arsenic exposed group (ﬁlled bars) compared to control (unﬁlled bars), did not differ. Data are mean ± SEM, n = 7–9. The intensity of the speciﬁc
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.10. Statistical analysis
Protein expression was normalized to the average of total pro-
ein expression evaluated by Coomassie staining. All data are
resented as mean ± SEM normalized to control values, and a
 value of <0.05 was set for statistical signiﬁcance. Data were
nalyzed by Student’s t-test using GraphPad software (GraphPad
oftware, v. 6.0; San Diego, CA) or, for the GSH/GSSH by a two-
ay ANOVA and the SAM and SAH data by three way ANOVA
SPSS, IBM v.22). The number of litters is reported for each exper-
ment, with only one animal per litter used to avoid litter con-
ounds.
. Results
.1. Impact of prenatal arsenic on GR, hydroxysteroid
ehydrogenase isozyme in female embryonic brain
To assess the impact of prenatal arsenate exposure on the
xpression of glucocorticoid receptor system in female brain tissue,
rotein levels of the glucocorticoid receptor, 11-Hsd isozymes
ere determined by western blot in both the post nuclear lysate
PNL) and the nuclear (Nuc) fraction from embryonic brain at
14 and E18 (Fig.1A–D) Unlike our ﬁndings with male embryonic
rain where we observed signiﬁcant effects of arsenic on the lev-
ls of GR and 11-Hsd isozymes, the females exposed to arsenate
uring development displayed no differences in protein levels for15).
GR or the 11-Hsd isozymes (Fig. 1 A–D). Since the female embryos
tested here were the siblings to those in our earlier study on the
male embryos [4], it indicates that the identical prenatal environ-
ment produced a sexually dimorphic effect. However, while the
protein expression was  unaltered (Fig. 1A–D), the mRNA for Nr3c1
(GR gene) was  signiﬁcantly elevated in the female E14 brain (Fig. 2A,
t(11) = 2.3, p = 0.04), but not altered at E18 (Fig. 2D). Similarly, 11-
Hsd-2 mRNA expression was  signiﬁcantly increased in the arsenic
exposed females (Fig. 2C, t(13) = 3.37, p = 0.005) at E14 but was not
different from controls at E18 (Fig. 2F). 11-Hsd-1 mRNA expres-
sion levels were not altered by arsenic at either developmental time
point (Fig. 2B and E)
3.2. Prenatal arsenic exposure (PAE) reduced methylation in
Nr3c1 promoter in the region encompassing SP-1 transcription
factor binding site, but not the Egr-1 region
In both male and female embryonic day 14 brain, arsenic
reduced the level of methylation in the SP-1 transcription factor
binding region of the Nr3c1 promoter (Fig. 3A and C, t(10) = 2.6,
p = .03) and t(10) = 2.2, p = .05 respectively). This effect was not
present just 4 gestational days later on E18 (Fig. 3B and D) in
either the male or female brain, suggesting a possible compen-
satory mechanism to counter the effect. Methylation in the egr-1
binding region of Nr3c1 was  not different in either male of female
offspring from the arsenic exposed dams at either gestational time
point (Fig. 4A–D).
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Fig. 8. The effect of prenatal arsenic (50 ppb) in male (top row) and female (bottom row) nuclear fractions from E14 (left column) and E18 (right column) brain on DNMT3b
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as  corrected to within blot Coomassie stain as described in (Caldwell et al., 2015)
.3. Prenatal arsenic exposure produced sex and age speciﬁc
hanges in the levels of methylation within the promoter region of
sd11b 1
Levels of methylation within the promoter region (Supple-
ental Fig. 3) of Hsd11b1 gene were signiﬁcantly lower in the
emale E14 brain (Fig. 5C [t(10) = 2.47, p = 0.003] and elevated at
18 [t(10) = 3.07, p = 0.012] exposed to prenatal arsenic (Fig. 5D).
ethylation levels were not altered by arsenic in male E14 (Fig. 5A)
r E18 (Fig. 5B) brain.
.4. Assessment of DNA methyltransferases (DNMTs) in response
o prenatal arsenic exposure
Given the observation that arsenic altered the level of methy-
ation within speciﬁc promoter regions of Nr3c1, we assessed the
evels of DNA methyltransferase. DNMT1 levels were not signiﬁ-
antly altered by prenatal arsenic in males (Fig. 6A and B) at either
14 or E18. Similarly, female arsenic exposed mice did not show a
hange in the levels of DNMT1 at either time point (Fig. 6C and D).
urther, DNMT3a and DNMT3b were not altered by prenatal arsenic
n either sex at either developmental time point (Figs. 7 and 8A–D).
lthough we should note that DNMT3b levels did approach signif-
cance (p = 0.064) in the male E18 mice.), did not differ. Data are mean ± SEM, n = 7–9. The intensity of the speciﬁc antibody
3.5. Assessment of MeCP2 levels in response to prenatal arsenic
exposure
MeCP2 is a part of a family of proteins which binds speciﬁ-
cally to methylated CpG domains on DNA but can also interact
with SIN3A to recruit histone deacetylases. Given our observa-
tion of changes in histone acetylation [43] and the indication
of altered methylated levels in the Nr3c1 promoter region, we
evaluated the levels of MeCP2 in E14 and E18 brain from
male and female PAE.No differences in MeCP2 protein levels
were found at either developmental time point in either sex
(Fig. 9).
3.6. Assessment of transcription factor levels in response to
prenatal arsenic exposure
Three primary transcription factors regulating Nr3c1 are Egr-1,
SP-1 and cJun. We assessed the levels of these transcription factors
in the nuclear fraction of the E14 and E18 male and female brain.
There were no signiﬁcant differences in any of the transcription
factor levels between control and arsenic at either developmental
time points for either sex (Supplemental Figs. 3–5).
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eCP2  protein expression. Arsenic exposed group (ﬁlled bars) compared to contro
ntibody was corrected to within blot Coomassie stain as described in (Caldwell et 
.7. Assessment of the levels of GSH and GSSH in liver and brain
t E18 in male and females following prenatal arsenic exposure
Reduced glutathione (-glutamylcysteinylglycine, GSH) is a
ajor tissue antioxidant. The formation of a disulﬁde bond between
wo GSH molecules gives rise to glutathione disulﬁde (GSSH or
SSG). During increased oxidative stress the levels of GSSH will
ise and the ratio of GSH to GSSH will decrease. GSH plays a
ey role in arsenic metabolism converting arsenate to arsenite.
evels of glutathione (GSH) and the reduced form (GSSH) were
ssessed both at end point, or assay completion, and as a kinetic
ssessment. This enzymatic reduction reaction also plays a crit-
cal role in the metabolic processing of arsenate. The levels of
SH/GSSH were measured in male and female liver and brain at
18 both at a pseudo-end point (Fig. 10A and C) and at multiple
imes during the reaction to provide an assessment of the kinetic
ate (Fig. 10 B and D). Using end point data, there was a signif-
cant prenatal effect [F(1,16) = 26.2, p = 0.0001] and a signiﬁcant
ex effect [F(1,16) = 16.08, p = 0.001], but no interaction present
Fig. 10A). At end point, arsenic increased the GSH/GSSH ratio in
oth male and female brain similarly, though female control tissue
ad higher GSH/GSSH levels than male controls (Fig. 10A, p = .003).
n brain, there was a prenatal treatment main effect [F(1,16) = 108.4, = 0.0001] and a sex main effect [F(1,16) = 175.8, p = 0.0001] and a
renatal × sex interaction [F(1,16) = 66.5, p = 0.0001] when the data
ere measured as a kinetic reaction (Fig. 10B). There was  a clear) nuclear (Nuc) fractions from E14 (left column) and E18 (right column) brain on
lled bars), did not differ. Data are mean ± SEM, n = 7–9. The intensity of the speciﬁc
15).
increase in GSH/GSSH ratio due to arsenic in the female brain tis-
sue (Fig. 10B, p = 0.005), indicating a greater oxidative capacity and
a more rapid enzymatic rate in female brain tissue. In the liver,
neither kinetic nor end point data revealed any signiﬁcant ﬁndings
(Fig. 10C and D).
3.8. Assessment of arsenic 3 methyltransferase and SAM levels
Arsenate is converted to arsenite by GSH then it is methylated
to monomethyl, dimethyl, and trimethyl forms by the combined
action of As3MT and SAM. We  evaluated the levels of As3MT
in the PNL fraction brain from male and female at E14 and E18
(Fig. 11A–D). There were no signiﬁcant differences in the levels
between the exposure groups at either developmental time-points
for ether sex (Fig. 11A–D).
S-adenosylmethionine (SAM) and its reduced form S-adenosyl
homocysteine (SAH) levels were determined in E14 and E18 from
arsenic and control male and female brain and liver (Table 2).
SAM/SAH ratio have been used to estimate the capacity of biolog-
ical methylation [7]. In brain, there was in signiﬁcant effect of age
for SAM [F(1,40) = 21.5, p = 0.0001] and SAH [F(1,40) = 5.6, p = 0.023]
levels. With age, brain levels of SAM increased overall and the levels
of SAH reduced. There were no effects of prenatal exposure or sex
nor interaction between any of the independent variables on brain
levels of SAM or SAH. Similarly in liver there was a signiﬁcant effect
of age on SAM [F(1,35) = 130.0, p = 0.0001] and SAH [F(1,35) = 59.1,
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Fig. 10. The effect of prenatal arsenic (50 ppb) in male (left) and female (right) brain (top row) and liver (bottom row) homogenates from E18 on glutathione enzymatic
activity expressed as the ratio GSH/GSSH. Data are taken at the single 4 min  end point (left column of ﬁgures) or as a kinetic reaction (right column of ﬁgures) integrated
every  minute for 4 min. Data are mean ± SEM, n = 5–8 with arsenic exposed group indicated in the ﬁlled bars compared to control unﬁlled bars.
Fig. 11. The effect of prenatal arsenic (50 ppb) in male (top row) and female (bottom row) post nuclear lysate (PNL) fractions from E14 (left column) and E18 (right column)
brain  on As3MT protein expression. Arsenic exposed group (ﬁlled bars) compared to control (unﬁlled bars), did not differ. Data are mean ± SEM, n = 7–9. The intensity of the
speciﬁc  antibody was  corrected to within blot Coomassie stain as described in (Caldwell et al., 2015).
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Table  3
Levels of arsenicals in brain from male and female E18 arsenic exposed mice. Data
are  presented as mean ppb ± SEM, n = 6–7.
In ppb AsV AsIII MMA  DMA
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aE18 male 1.6 (±0.2) 0.28 (±0.02) 0.02 (±0.001) 0.13 (±0.04)
E18 female 1.3 (±0.2) 0.34 (±0.03) 0.03 (±0.001) 0.14 (±0.03)
 = 0.0001] but unlike the brain the levels of both SAM and SAH
ecreased with age. In liver, there was a signiﬁcant interaction
etween age and sex for SAH levels [F(1,35) = 10.5, p = 0.003]. The
ature of the interaction was due to a sharper decrease in the
emales due to age than in the males. The very low SAH levels in
he control males at E14 is the likely source. No other main effects
r interactions were signiﬁcant.
.9. Levels of arsenate, arsenite, monomethylarsenicals (MMA III)
nd dimethylated arsenicals (DMA V) in male and female E18
rain
A possible sex dependent difference in the bioaccumulation of
rsenicals in the fetal brain was assessed at E18 using our previ-
usly published ICP-MS procedures [4]. There were no signiﬁcant
ex differences in the levels of any of the arsenicals measured.There
as a greater concentration of arsenate compared with arsenite
nd higher levels of DMA  relative to MMA  (Table 3).
. Discussion
During development, methylation and demethylation of DNA
nd posttranslational modiﬁcations of histones are dynamically
nvolved in regulating gene and protein levels in a temporal and
ell speciﬁc manner. Dysregulation of the extent and timing of these
pigenetic controls by environmental toxins can alter the develop-
ental programming of key biological systems. Determining the
mpact of fetal toxic exposures on the status of factors associ-
ted with epigenetic control of genetic programs could provide
nsight into how fetal programming leads to disease susceptibil-
ty in adulthood. While the impact of arsenic exposure on the
pigenome has been extensively studied in the context of cancer
esearch, the inﬂuence of this toxicant in the developing brain, par-
icularly as it relates to epigenetics, is not well understood. Arsenic
as been shown to alter the levels of histone methylation [8] and
NA methylation [35], but only a few have explored potential
ex-dependent effects of prenatal arsenic on epigenetic modiﬁca-
ions [29,3,43]. A study of mother newborn pairs from Bangladesh
ound DNA methylation was increased in male, but not female,
ewborn cord blood [29]. In our own work, we found developmen-
al exposure in mice to 50 ppb arsenic affected histone3 lysine9
rimethylation patterns in a sex and brain region dependent man-
er [43]. The study presented here extends these sex dependent
ffect of prenatal arsenic.
In our previous studies, we found that in male embryos arsenic
xposure signiﬁcantly decreased expression of both protein and
RNA in brain of GR and the 11-HSD1 enzyme [4]. Expression
f 11HSD1 plays a key role in glucorticoid synthesis and in the
xpression and set point of the GR negative feedback regulation.
his feedback regulation mechanism is established early in devel-
pment (about E16.5). In adult arsenic exposed males we  observed
 continuing failure of GR negative feedback regulation along with
 persistent decrease in GR and 11-HSD1 [11,4].
In the present study examining arsenic exposed female-
mbryos, we found no changes in the protein levels of GR,
1-HSD1, and 11-HSD2. However, there was  an increase in
r3c1 (GR) and Hsd11b2 message at E14 in the brain from female
rsenic exposed condition.These ﬁndings were quite different fromorts 2 (2015) 1376–1390 1387
those we  observed in the male fetus [4]. In the males, prenatal
arsenic produced a decrease in mRNA for Nr3c1, Hsd11b1, and
Hsd11b2 at E14 along with a decrease in protein expression of
GR and 11-Hsd1 but an increase in 11-Hsd2.This increase in
11-Hsd2 along with the decrease in 11-Hsd1 could indicate a
developmental delay in the males. Normally, there should be an
increase in 11-Hsd1 expression with a corresponding decrease
in11-Hsd2 at E18. In the present data looking at females, the
only signiﬁcant changes in mRNA due to arsenic exposure was
an increase in Nr3c1 and Hsd11B2 at E14 with no correspond-
ing changes in these proteins. The ﬁndings suggest that there is
a translational regulation which is occurring within the females in
response to arsenic that is not engaged in the male exposed fetal
brains. To our knowledge, these studies are the ﬁrst to demonstrate
that gestational exposure to moderate levels of arsenic results in
sexually dimorphic changes to the glucocorticoid system.
Levels of methylation within the CpG islands surveyed in our
study found that arsenic exposure at E14 reduced methylation in
both male and female for the SP-1 transcription factor binding area
of the promoter (region-1, corresponding to the promoter region
of exon 1f) of Nr3c1 but not the Egr-1 binding region (region 6).
In general, the levels of methylation in these regions of Nr3c1
inversely correlate with the levels of glucocorticoid mRNA and
often the levels of protein as well [23,28]. In E14 males, prena-
tal arsenic decreased the levels of methylation in region 1 (Fig. 3),
but decreased Nr3c1 mRNA and decreased GR protein levels [4]. In
females, while we did observe an increase in the levels of Nr3c1
mRNA at E14, we  did not see a corresponding increase in GR pro-
tein, suggesting a decreased translation rate or a post translational
regulation.
11Hsd-1 is commonly found in tissues co-localized with GR
[39]. Levels of Hsd11b1 mRNA can be increased by corticosterone
and activity at the GR suggesting that there is a feed-forward system
between GR and Hsd11b1 [51]. It is believed that this relationship
between GR and 11Hsdb1 is also key to establishing GR nega-
tive feedback regulation [5]. The 11Hsdb1 gene has two promoter
sites; promoter site 1 contains a glucocorticoid response element
and promoter site 2 contains a CCAAT/enhancer-binding protein
(C/EBP) transcription factor site which is required for GR regula-
tion of Hsd11b1 [49,36]. Since we had already demonstrated that
the GR levels were altered in male brain in response to arsenic
[4], the primers we  used were designed to target promoter 2. For
Hsd11b1, fold methylation was  decreased in the arsenic exposed
females at E14, but then increased relative to controls at E18. This
differential regulation between the two  time points is a bit surpris-
ing as normally expression of Hsd11b1 should be increasing by E18.
However, while there were signiﬁcant methylation changes in the
females, there were no corresponding mRNA or protein changes in
Hsd11b1 due to arsenic exposure.Arsenic has been shown to down
regulate C/EBP in mesenchymal stem cells [50] and reduce the bind-
ing of C/EBP to DNA in adipocytes [12]. It is possible that, while there
was altered methylation at this site in the female arsenic exposed
mice, arsenic mediated changes in the levels of C/EBP could have
occurred. Interestingly, there were no methylation changes seen
in the Hsd11b1 promoter in the male arsenic exposed mice. We
evaluated the levels of several transcription factors including Egr-
1, cJun and SP-1 (Supplemental Figs. 3–5) and found no effect of
sex or arsenic exposure, but we  have not assessed C/EBP. While
it is intriguing to speculate that there are changes to c/EBP in our
arsenic exposure model, future studies would be needed to test this
hypothesis.
These age and sex speciﬁc methylation changes indicate that
it is unlikely arsenic is producing a global methylation change
and suggests there is a dynamically regulated epigenetic process.
In support of this conclusion, we  did not observe any signiﬁcant
changes in the levels of DNMT1, DNMT3a or 3b, which would be
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xpected if there were global methylation differences due to arsenic
n our embryos [6].
Finally, because most mammals enzymatically convert inor-
anic arsenic (iAs) into methylated metabolites, predominately
ono- and dimethylated arsenicals we examined the levels and
ctivities of the key enzymes and methyl donor compounds in the
ale and female brain and liver. To conﬁrm that male and female
etuses were being exposed to the same levels of arsenic and were
enerating the same levels of speciated forms, we  assessed E18
rain levels of arsenite, arsenate, MMA,  and DMA  levels. In our stud-
es, we observed the largest portion of iAs as arsenate with 15% as
rsenite in males and about 20% as arsenite in the female brain at
18.There were no statistically signiﬁcant differences between the
exes in the arsenical species, suggesting that arsenate metabolism
s not signiﬁcantly impacted by the sex of the fetus. A study by Lu
t al. [18] indicates when pregnant mice are treated with either
0 ppm arsenate or arsenite in their water throughout gestation
hat As(III) levels accumulate in the liver when measured on post-
atal day (PND) 1–35. It is thought that the arsenite could possibly
roduce a greater interference of methylation potential in the off-
pring than As (V), because the levels of DMA  were greater at PND1
n the As(III) treated group. However, they do report that the lev-
ls of iAs were similar in liver at PND 1 and PND10 and that the
MA levels were not different at PND10 and PND15. Additionally,
he authors note that in the brain exposure with either arsenate
r arsenite produces similar levels of iAs and DMA  accumulation
rom PND10–21, likely due to an immature blood brain barrier in
he early stages of gestation.Although the Lu et al. [18] study did
ot separately assess male and female offspring at PND 1 and their
ork was conducted on postnatal time points, our ﬁndings are in
eneral agreement.
In vivo, arsenate is converted to arsenite via glutathione
45,25,48] followed by the conversion to MMA  and DMA  with
he combined action of S-adenosylmethionine (SAM) and As3MT.
iven the critical role of glutathione and SAM in the generation
f methyl donor groups it has been suggested that arsenic expo-
ures can affect the levels or activity of these enzymes and thereby
lter the ability to methylate DNA and histones. We  assessed the
evels of glutathione, As3MT, and SAM/SAH in the arsenic exposed
ale and female embryos. We  did not observe a difference in the
evels of As3MT between the male and female arsenic exposed
rains at either E14 or E18. This is in contrast to a study using
rogs which showed 0.5–100 ppm arsenate ﬁrst decreased As3MT
t the lower level of exposure but then produced an increase in
s3MT levels in the 100 ppm concentration condition [14], thus it
s possible that at higher arsenate exposures As3MT levels could be
ffected.
In our study, there was a signiﬁcant difference between male
nd female fetal brain in the ratio of GSH/GSSH. Female brain
issue from arsenic exposed embryos had an elevated GSH/GSSH
atio; which was particularly noted when the glutathione assay
as conducted using a kinetic analysis. This relationship was  not
een in liver, however, as there was no sex difference nor an
ffect of arsenic exposure. Brain GSH levels are produced locally
nd are limited by the available levels of l-cysteine [46]. The
ex differences in brain GSH/GSSH ratios are interesting, but not
ntirely surprising. There is evidence that females may  have a
ore rapid development of the enzymes within this anti- oxida-
ive pathway. Levels of glutathione peroxidase mRNA were higher
n female mice early in the postnatal period [41]. Cysteine uptake,
 key component of glutathione, is greater in female prema-
ure infants than male counterparts [16]. Glutathione-S-transferase
evels have also been reported to be higher in females than
ales [15]. These ﬁndings are in agreement with the ﬁndings
f Ramos-Chavez et al. [31], where they observed higher lev-
ls of GSH in postnatal day 15 hippocampus from female butorts 2 (2015) 1376–1390
not male offspring of arsenic exposed dams. This suggests that
there may  be a greater redox rate in females exposed to prenatal
arsenic. However, despite this difference, the levels of arsenicals
were not different between the male and female fetal brain tis-
sue, suggesting that at these low levels of arsenate (50 ppb) the
glutathione rate difference had no substantive effect on arsenic
metabolism. Interestingly, like the present study, Ramos-Chavez
et al. [31] also did not ﬁnd a difference between the sexes in
the brain levels of arsenic species. Thus, while it is assumed
that arsenic metabolism will utilize and perhaps deplete the
enzymes needed for epigenetic methylation, our study using a
50 ppb arsenate exposure during gestation did not produce signif-
icant decreases in these enzymes. There is evidence that arsenate
is being metabolized and converted to arsenite and the MMA
and DMA  forms but this metabolic activity was  not demanding
enough to produce a substantive change in the levels of these
enzymes.
While the levels of SAM and SAH changed with age, we did
not observe any impact of prenatal arsenic or sex on the levels
measured in either brain or liver. The fact that arsenic exposure
did not alter brain levels of SAM or SAH is not surprising since
Rios et al. [34] reported 3 ppm arsenic exposures did not affect
the levels of brain SAM in adult female mice. They did, however,
observe a decrease in the liver from these mice. The total levels
of brain and liver SAM in the Rios et al. [34] study are substan-
tially greater (mol/g tissue) than were observed (nmol/g tissue)
in our study using embryonic tissue. These ﬁndings along with the
lack of an arsenic effect on As3MT and a lack of an effect over-
all on GSH/GSSH levels, suggests that the changes in methylation
seen in the Hsd11b1 and Nr3c1 promoter regions are not likely
the result of the depletion of methyl donor groups due to arsenic
metabolism. However, we  should note that enzyme activity rates
were not measured for As3MT and, while the steady state assess-
ment did not change due to arsenic exposure, it is possible that
the rates of the reactions were altered by the exposures which
could have altered the dynamic levels of methyl donor groups.
Moreover, the levels of arsenic tested in this study are signiﬁcantly
lower than others where changes in SAM and glutathione were
reported.
5. Conclusion
In summary, prenatal arsenate exposure (50 ppb) produced
signiﬁcant sex dependent effects on the glucocorticoid system
in embryonic brain.Compared to the impact on males, females
were resistant to arsenic induced changes in GR, 11-Hsd-1, and
11-Hsd-2 proteins despite elevations in Nr3c1 and Hsd11b2
mRNA.This sexual dimorphic effect on GR could not be accounted
for by altered promoter methylation since both male and female
exposed fetal brain showed a decrease in methylation at E14.
Unlike the males, females exposed to arsenate at E14 showed a
decrease in methylation of Hsd11b1 gene, but no corresponding
mRNA increase. There were no changes in the key transcription
factors, DNMTs, to explain this differential effect. With respect to
arsenate metabolism, males and females exposed to 50 ppb arse-
nate had similar levels of As3MT and SAM, however, there was
an indication that the GSH/GSSH production rate was faster in
the females. It is possible that this greater anti-oxidative capac-
ity within the females provides protection against low to moderate
arsenate. Finally, our data provides evidence that prenatal arsenic
exposure impacts levels of methylation of targeted regions within
the promoter of the glucocorticoid receptor gene (Nr3c1) and in
females, alters methylation status of the hydroxysteroid dehydro-
genase 1 gene (Hsd11b1) in an age speciﬁc manner.
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